CROX vs TMO · rev $4.10B vs P/E 24, rev $44.56B
Crocs Inc (CROX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Crocs Inc (CROX) is a footwear & accessories company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CROX revenue for 2024-12-31 was $4.10B. Net income was $950.1M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. CROX currently screens at market cap $5.93B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CROX currently screens at market cap $5.93B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CROX and TMO stock pages for the full models.
Not investment advice.